{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:38:08Z","timestamp":1793295488457,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100029394","name":"American Academy of Family Physicians","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100029394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG071151"],"award-info":[{"award-number":["R01AG071151"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["U1QHP28710"],"award-info":[{"award-number":["U1QHP28710"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1R01AG074258"],"award-info":[{"award-number":["1R01AG074258"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG076525"],"award-info":[{"award-number":["R01AG076525"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013965","name":"Eastern Virginia Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008102","name":"University of Cincinnati","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["UF1NS100588"],"award-info":[{"award-number":["UF1NS100588"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS124065"],"award-info":[{"award-number":["1R01NS124065"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Radiology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jacr.2025.02.031","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T11:27:17Z","timestamp":1747826837000},"page":"S202-S233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"S","title":["ACR Appropriateness Criteria\u00ae Dementia: 2024 Update"],"prefix":"10.1016","volume":"22","author":[{"given":"Karl A.","family":"Soderlund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharona","family":"Ben-Haim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammy","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Ivanidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleks","family":"Kalnins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambar","family":"Kulshreshtha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip H.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Masdeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejas","family":"Nikumbh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno P.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashesh A.","family":"Thaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily L.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevil","family":"Yasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Y.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacr.2025.02.031_bib1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and management of dementia: review","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacr.2025.02.031_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association Workgroups on Diagnostic Guidelines for Alzheimer\u2019s Disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jacr.2025.02.031_bib3","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2967\/jnumed.111.089730","article-title":"Amyloid imaging with F-florbetaben in Alzheimer disease and other dementias","volume":"52","author":"Villemagne","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jacr.2025.02.031_bib4","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","article-title":"Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study","volume":"73","author":"Okello","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jacr.2025.02.031_bib5","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3233\/JAD-230950","article-title":"Elevated amyloid-beta PET scan and cognitive and functional decline in mild cognitive impairment and dementia of uncertain etiology","volume":"97","author":"Plassman","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jacr.2025.02.031_bib6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jnnp-2017-316194","article-title":"Clinical utility of amyloid PET imaging with F-florbetapir: a retrospective study of 100 patients","volume":"89","author":"Carswell","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jacr.2025.02.031_bib7","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jamaneurol.2018.1346","article-title":"Association of amyloid positron emission tomography with changes in diagnosis and patient treatment in an unselected memory clinic cohort: the ABIDE project","volume":"75","author":"de Wilde","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jacr.2025.02.031_bib8","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s00259-019-04297-5","article-title":"Clinical impact of [F]flutemetamol PET among memory clinic patients with an unclear diagnosis","volume":"46","author":"Leuzy","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jacr.2025.02.031_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2967\/jnumed.119.230797","article-title":"Predictive value of F-florbetapir and F-FDG PET for conversion from mild cognitive impairment to Alzheimer dementia","volume":"61","author":"Blazhenets","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jacr.2025.02.031_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/0891988706291089","article-title":"Diagnostic issues in dementia: neuroimaging as a surrogate marker of disease","volume":"19","author":"Small","year":"2006","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.jacr.2025.02.031_bib12","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2967\/jnumed.107.045385","article-title":"Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer\u2019s disease, and other dementias","volume":"49","author":"Mosconi","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jacr.2025.02.031_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jalz.2007.08.006","article-title":"Core candidate neurochemical and imaging biomarkers of Alzheimer\u2019s disease","volume":"4","author":"Hampel","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jacr.2025.02.031_bib14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00259-020-04969-7","article-title":"Clinical impact of F-FDG-PET among memory clinic patients with uncertain diagnosis","volume":"48","author":"Perini","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jacr.2025.02.031_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102754","article-title":"FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD","volume":"31","author":"Kantarci","year":"2021","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.jacr.2025.02.031_bib16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.nic.2005.09.013","article-title":"A review of 1H MR spectroscopy findings in Alzheimer\u2019s disease","volume":"15","author":"Soher","year":"2005","journal-title":"Neuroimaging Clin N Am"},{"issue":"Spec No 2","key":"10.1016\/j.jacr.2025.02.031_bib17","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1259\/bjr\/60346217","article-title":"1H magnetic resonance spectroscopy in dementia","volume":"80","author":"Kantarci","year":"2007","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jacr.2025.02.031_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jns.2013.08.023","article-title":"Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia","volume":"335","author":"Targosz-Gajniak","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jacr.2025.02.031_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbadis.2011.07.008","article-title":"Imaging the default mode network in aging and dementia","volume":"1822","author":"Hafkemeijer","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacr.2025.02.031_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101958","article-title":"Evidence of parietal hyperactivation in individuals with mild cognitive impairment who progressed to dementia: a longitudinal fMRI study","volume":"24","author":"Corriveau-Lecavalier","year":"2019","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.jacr.2025.02.031_bib21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/brain\/awr327","article-title":"Functional connectivity in cortical regions in dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"135","author":"Kenny","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jacr.2025.02.031_bib22","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/brain\/awp123","article-title":"Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer\u2019s disease","volume":"132","author":"Desikan","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jacr.2025.02.031_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jacr.2025.02.031_bib24","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1258\/ar.2011.100430","article-title":"Evaluation of apparent diffusion coefficient mappings in amnestic mild cognitive impairment using an image analysis software brain search","volume":"52","author":"Zhang","year":"2011","journal-title":"Acta Radiol"},{"key":"10.1016\/j.jacr.2025.02.031_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neurobiolaging.2013.06.018","article-title":"Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer\u2019s dementia","volume":"35","author":"Trzepacz","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jacr.2025.02.031_bib26","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/MNM.0000000000001415","article-title":"F-18 ML-104 tau PET imaging in mild cognitive impairment","volume":"42","author":"Jaleel","year":"2021","journal-title":"Nucl Med Commun"},{"issue":"Suppl 9","key":"10.1016\/j.jacr.2025.02.031_bib27","first-page":"S98","article-title":"Amyloid and tau-PET in early-onset AD: baseline data from the Longitudinal Early-Onset Alzheimer\u2019s Disease Study (LEADS)","volume":"19","author":"Cho","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jacr.2025.02.031_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1148\/rg.2020190070","article-title":"Multimodality imaging of dementia: clinical importance and role of integrated anatomic and molecular imaging","volume":"40","author":"Patel","year":"2020","journal-title":"Radiographics"},{"key":"10.1016\/j.jacr.2025.02.031_bib29","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacr.2025.02.031_bib30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jacr.2025.02.031_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jacr.2025.02.031_bib32","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.2967\/jnumed.121.263195","article-title":"The role of amyloid PET in imaging neurodegenerative disorders: a review","volume":"63","author":"Chapleau","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jacr.2025.02.031_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jacr.2025.02.031_bib34","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jacr.2025.02.031_bib35","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.2967\/jnumed.119.240325","article-title":"Amyloid PET in dementia syndromes: a Chinese multicenter study","volume":"61","author":"Shi","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jacr.2025.02.031_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cercor\/bhaa184","article-title":"Spatial relationships between molecular pathology and neurodegeneration in the Alzheimer\u2019s disease continuum","volume":"31","author":"Iaccarino","year":"2021","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.jacr.2025.02.031_bib37","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2967\/jnumed.109.069088","article-title":"In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)","volume":"51","author":"Wong","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jacr.2025.02.031_bib38","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jama.2015.4669","article-title":"Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis","volume":"313","author":"Ossenkoppele","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacr.2025.02.031_bib39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00259-018-4111-3","article-title":"Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [F]FDG PET","volume":"46","author":"Hellwig","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jacr.2025.02.031_bib40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/WAD.0000000000000575","article-title":"Utility of amyloid PET imaging in a memory clinic","volume":"37","author":"Pletnikova","year":"2023","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jacr.2025.02.031_bib41","first-page":"141","article-title":"The role of PET\/CT amyloid Imaging compared with Tc99m-HMPAO SPECT imaging for diagnosing Alzheimer\u2019s disease","volume":"73","author":"Suppiah","year":"2018","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.jacr.2025.02.031_bib42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.25968","article-title":"Diagnostic accuracy of amyloid versus F-fluorodeoxyglucose positron emission tomography in autopsy-confirmed dementia","volume":"89","author":"Lesman-Segev","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jacr.2025.02.031_bib43","first-page":"101","article-title":"CT diagnostic features of Alzheimer disease: importance of the choroidal\/hippocampal fissure complex","volume":"11","author":"George","year":"1990","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jacr.2025.02.031_bib44","first-page":"21","article-title":"Direct comparison of spatially normalized PET and SPECT scans in Alzheimer\u2019s disease","volume":"43","author":"Herholz","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jacr.2025.02.031_bib45","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","article-title":"Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"56","author":"Knopman","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jacr.2025.02.031_bib46","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1017\/S1041610213002317","article-title":"Assessment of regional MR diffusion changes in dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"26","author":"O\u2019Donovan","year":"2014","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jacr.2025.02.031_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1148\/radiol.2018170575","article-title":"Alzheimer disease and mild cognitive impairment: integrated pulsed arterial spin-labeling MRI and F-FDG PET","volume":"288","author":"Riederer","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2025.02.031_bib48","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/jnnp.64.3.306","article-title":"A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?","volume":"64","author":"Talbot","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jacr.2025.02.031_bib49","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1080\/02841850802438512","article-title":"Voxel-based correlation between coregistered single-photon emission computed tomography and dynamic susceptibility contrast magnetic resonance imaging in subjects with suspected Alzheimer disease","volume":"49","author":"Cavallin","year":"2008","journal-title":"Acta Radiol"},{"key":"10.1016\/j.jacr.2025.02.031_bib50","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3174\/ajnr.A1926","article-title":"Differential diagnosis of dementia with Lewy bodies and Alzheimer disease using combined MR imaging and brain perfusion single-photon emission tomography","volume":"31","author":"Goto","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jacr.2025.02.031_bib51","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jalz.2019.09.079","article-title":"Tau-positron emission tomography correlates with neuropathology findings","volume":"16","author":"Lowe","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jacr.2025.02.031_bib52","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamaneurol.2020.0989","article-title":"Diagnostic performance of RO948 F 18 tau positron emission tomography in the differentiation of Alzheimer disease from other neurodegenerative disorders","volume":"77","author":"Leuzy","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jacr.2025.02.031_bib53","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2018.12917","article-title":"Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders","volume":"320","author":"Ossenkoppele","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacr.2025.02.031_bib54","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jalz.2018.12.001","article-title":"Predicting diagnosis and cognition with F-AV-1451 tau PET and structural MRI in Alzheimer\u2019s disease","volume":"15","author":"Mattsson","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jacr.2025.02.031_bib55","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1212\/CON.0000000000001082","article-title":"Atypical Alzheimer disease variants","volume":"28","author":"Polsinelli","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.jacr.2025.02.031_bib56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jalz.2017.09.009","article-title":"Added value of F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study","volume":"14","author":"Ceccaldi","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jacr.2025.02.031_bib57","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00259-018-4032-1","article-title":"Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer\u2019s disease","volume":"45","author":"Drzezga","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jacr.2025.02.031_bib58","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/MNM.0000000000001102","article-title":"Metabolic imaging patterns in posterior cortical atrophy and Lewy body dementia","volume":"40","author":"Gupta","year":"2019","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.jacr.2025.02.031_bib59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jalz.2019.08.201","article-title":"Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer\u2019s disease","volume":"16","author":"Ossenkoppele","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jacr.2025.02.031_bib60","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/hbm.23874","article-title":"Tau PET imaging predicts cognition in atypical variants of Alzheimer\u2019s disease","volume":"39","author":"Phillips","year":"2018","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.jacr.2025.02.031_bib61","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mds.27603","article-title":"F-AV-1451 uptake differs between dementia with Lewy bodies and posterior cortical atrophy","volume":"34","author":"Nedelska","year":"2019","journal-title":"Mov Disord"},{"key":"10.1016\/j.jacr.2025.02.031_bib62","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use recommendations","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.jacr.2025.02.031_bib63","doi-asserted-by":"crossref","DOI":"10.1148\/rg.230009","article-title":"Amyloid-related imaging abnormalities in Alzheimer disease treated with anti-amyloid-beta therapy","volume":"43","author":"Agarwal","year":"2023","journal-title":"Radiographics"},{"key":"10.1016\/j.jacr.2025.02.031_bib64","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/WCO.0000000000001177","article-title":"MRI in the new era of antiamyloid mAbs for the treatment of Alzheimer\u2019s disease","volume":"36","author":"Filippi","year":"2023","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jacr.2025.02.031_bib65","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/WNL.0000000000207757","article-title":"Antiamyloid monoclonal antibody therapy for Alzheimer disease: emerging issues in neurology","volume":"101","author":"Ramanan","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.jacr.2025.02.031_bib66","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jacr.2025.02.031_bib67","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/WCO.0000000000001198","article-title":"Advanced brain imaging for the diagnosis of Alzheimer disease","volume":"36","author":"Wang","year":"2023","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jacr.2025.02.031_bib68","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1053\/j.semnuclmed.2020.12.002","article-title":"Molecular and anatomical imaging of dementia with Lewy bodies and frontotemporal lobar degeneration","volume":"51","author":"Duignan","year":"2021","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.jacr.2025.02.031_bib69","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41572-023-00447-0","article-title":"Frontotemporal lobar degeneration","volume":"9","author":"Grossman","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jacr.2025.02.031_bib70","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11910-014-0489-x","article-title":"Imaging frontotemporal lobar degeneration","volume":"14","author":"Diehl-Schmid","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jacr.2025.02.031_bib71","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1212\/01.WNL.0000069462.11741.EC","article-title":"Loss of frontal fMRI activation in early frontotemporal dementia compared to early AD","volume":"60","author":"Rombouts","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jacr.2025.02.031_bib72","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1212\/WNL.0000000000000583","article-title":"Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia","volume":"83","author":"Dopper","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jacr.2025.02.031_bib73","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1007\/s00415-023-12087-1","article-title":"Cortical thickness modeling and variability in Alzheimer\u2019s disease and frontotemporal dementia","volume":"271","author":"Perez-Millan","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.jacr.2025.02.031_bib74","doi-asserted-by":"crossref","first-page":"e1218","DOI":"10.1212\/WNL.0000000000207600","article-title":"Association of choroid plexus volume with serum biomarkers, clinical features, and disease severity in patients with frontotemporal lobar degeneration spectrum","volume":"101","author":"Assogna","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.jacr.2025.02.031_bib75","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3233\/JAD-2012-121156","article-title":"MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes","volume":"33","author":"Zhang","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jacr.2025.02.031_bib76","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-019-0470-7","article-title":"F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes","volume":"11","author":"Tsai","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jacr.2025.02.031_bib77","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neurobiolaging.2018.11.017","article-title":"F-flortaucipir uptake patterns in clinical subtypes of primary progressive aphasia","volume":"75","author":"Cho","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jacr.2025.02.031_bib78","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/brain\/awab057","article-title":"Neuroinflammation is highest in areas of disease progression in semantic dementia","volume":"144","author":"Pascual","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.jacr.2025.02.031_bib79","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3174\/ajnr.A7079","article-title":"Complete evaluation of dementia: PET and MRI correlation and diagnosis for the neuroradiologist","volume":"42","author":"Oldan","year":"2021","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jacr.2025.02.031_bib80","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jagp.2013.03.001","article-title":"Amyloid PET imaging in Lewy body disorders","volume":"23","author":"Donaghy","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jacr.2025.02.031_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120719","article-title":"Clinical validation of the cingulate island sign visual rating scale in dementia with Lewy bodies","volume":"451","author":"Feng","year":"2023","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jacr.2025.02.031_bib82","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.neurobiolaging.2014.01.001","article-title":"Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies","volume":"35","author":"Graff-Radford","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jacr.2025.02.031_bib83","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1017\/S1041610215001805","article-title":"Subcortical volume changes in dementia with Lewy bodies and Alzheimer\u2019s disease. A comparison with healthy aging","volume":"28","author":"Watson","year":"2016","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jacr.2025.02.031_bib84","doi-asserted-by":"crossref","first-page":"e1843","DOI":"10.1212\/WNL.0000000000200947","article-title":"Longitudinal patterns of cortical atrophy on MRI in patients with Alzheimer disease with and without Lewy body pathology","volume":"99","author":"Constant","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.jacr.2025.02.031_bib85","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.acra.2008.04.008","article-title":"Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia","volume":"15","author":"Fayed","year":"2008","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jacr.2025.02.031_bib86","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s12149-008-0193-5","article-title":"Value of analyzing deep gray matter and occipital lobe perfusion to differentiate dementia with Lewy bodies from Alzheimer\u2019s disease","volume":"22","author":"Shimizu","year":"2008","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.jacr.2025.02.031_bib87","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000208015","article-title":"99mTc-HMPAO SPECT perfusion signatures associated with clinical progression in patients with isolated REM sleep behavior disorder","volume":"102","author":"Rahayel","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.jacr.2025.02.031_bib88","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1007\/s00259-023-06154-y","article-title":"The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review","volume":"50","author":"Jreige","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jacr.2025.02.031_bib89","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.2967\/jnumed.119.239418","article-title":"Confirmation of I-FP-CIT SPECT quantification methods in dementia with Lewy bodies and other neurodegenerative disorders","volume":"61","author":"Maltais","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jacr.2025.02.031_bib90","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","article-title":"Tau positron emission tomographic imaging in the Lewy body diseases","volume":"73","author":"Gomperts","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jacr.2025.02.031_bib91","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neurobiolaging.2020.11.006","article-title":"Imaging tau burden in dementia with Lewy bodies using [F]-AV1451 positron emission tomography","volume":"101","author":"Mak","year":"2021","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jacr.2025.02.031_bib92","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/CON.0000000000001124","article-title":"Vascular cognitive impairment and dementia","volume":"28","author":"Chang Wong","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.jacr.2025.02.031_bib93","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000531088","article-title":"Imaging, genetic, and pathological features of vascular dementia","volume":"86","author":"Yang","year":"2023","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jacr.2025.02.031_bib94","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00415-005-0624-3","article-title":"Cerebrovascular reactivity and dynamic autoregulation in nondemented patients with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)","volume":"252","author":"Singhal","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.jacr.2025.02.031_bib95","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"Roman","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jacr.2025.02.031_bib96","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3233\/JAD-191046","article-title":"Neuroimaging in vascular cognitive impairment and dementia: a systematic review","volume":"73","author":"Frantellizzi","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jacr.2025.02.031_bib97","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3174\/ajnr.A2782","article-title":"Imaging approaches for dementia","volume":"33","author":"Murray","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jacr.2025.02.031_bib98","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/ene.13728","article-title":"European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus","volume":"25","author":"Nobili","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jacr.2025.02.031_bib99","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mrm.1910260211","article-title":"Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities","volume":"26","author":"Sappey-Marinier","year":"1992","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jacr.2025.02.031_bib100","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1161\/STROKEAHA.107.507475","article-title":"Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time","volume":"39","author":"Nitkunan","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jacr.2025.02.031_bib101","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000358119","article-title":"Cerebral microbleeds are not associated with long-term cognitive outcome in patients with transient ischemic attack or minor stroke","volume":"37","author":"Brundel","year":"2014","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jacr.2025.02.031_bib102","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1017\/cjn.2022.65","article-title":"Brain imaging abnormalities in mixed Alzheimer\u2019s and subcortical vascular dementia","volume":"50","author":"Lee","year":"2023","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.jacr.2025.02.031_bib103","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1212\/WNL.0000000000002193","article-title":"Practice guideline: idiopathic normal pressure hydrocephalus: response to shunting and predictors of response: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"85","author":"Halperin","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jacr.2025.02.031_bib104","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.wneu.2023.10.110","article-title":"Magnetic resonance imaging diagnosis in normal pressure hydrocephalus","volume":"181","author":"Giorgio","year":"2024","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jacr.2025.02.031_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186523","article-title":"Usefulness of brain positron emission tomography with different tracers in the evaluation of patients with idiopathic normal pressure hydrocephalous","volume":"21","author":"Mattoli","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacr.2025.02.031_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102481","article-title":"CSF dynamics disorders: Association of brain MRI and nuclear medicine cisternogram findings","volume":"28","author":"Cogswell","year":"2020","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.jacr.2025.02.031_bib107","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.nicl.2018.02.031","article-title":"F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus","volume":"18","author":"Townley","year":"2018","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.jacr.2025.02.031_bib108","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1259\/bjr\/43131041","article-title":"Proton MR spectroscopy and white matter hyperintensities in idiopathic normal pressure hydrocephalus and other dementias","volume":"83","author":"Algin","year":"2010","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jacr.2025.02.031_bib109","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1212\/CON.0000000000000319","article-title":"Rapidly progressive dementia","volume":"22","author":"Geschwind","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.jacr.2025.02.031_bib110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3174\/ajnr.A3454","article-title":"Neuroimaging of rapidly progressive dementias, part 1: neurodegenerative etiologies","volume":"35","author":"Degnan","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jacr.2025.02.031_bib111","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3174\/ajnr.A3455","article-title":"Neuroimaging of rapidly progressive dementias, part 2: prion, inflammatory, neoplastic, and other etiologies","volume":"35","author":"Degnan","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jacr.2025.02.031_bib112","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00415-023-11962-1","article-title":"MRI abnormalities in Creutzfeldt-Jakob disease and other rapidly progressive dementia","volume":"271","author":"Manara","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.jacr.2025.02.031_bib113","article-title":"Dural arteriovenous fistula presenting as a rapidly progressive thalamic dementia: a case report","volume":"14","author":"Khan","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jacr.2025.02.031_bib114","series-title":"Measuring sex, gender identity, and sexual orientation","article-title":"Measuring sex, gender identity, and sexual orientation","year":"2022"}],"container-title":["Journal of the American College of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144025001371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144025001371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:22:54Z","timestamp":1762550574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1546144025001371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":113,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1546144025001371"],"URL":"https:\/\/doi.org\/10.1016\/j.jacr.2025.02.031","relation":{},"ISSN":["1546-1440"],"issn-type":[{"value":"1546-1440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACR Appropriateness Criteria\u00ae Dementia: 2024 Update","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacr.2025.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Radiology","name":"copyright","label":"Copyright"}]}}